Patient Access KPIs: A Simple List for Market Access and Patient Services Teams

In the specialty pharmaceutical world, patient access is everything. No matter how effective a therapy is, the value is only realized when patients can start, stay on, and succeed with treatment. Yet many pharma and patient services teams still struggle to track access performance clearly. Data sits in silos across hubs, SPs, field teams, payers, and PSP vendors making it hard to know where patients get stuck and what needs fixing.

This is where Patient Access KPIs (Key Performance Indicators) become essential. A well designed KPI set helps Market Access, Patient Services, and Commercial teams monitor the health of the access journey end to end. It brings clarity, speed, and actionability.

Below is a simple, practical list of the most important KPIs every specialty brand should monitor.

1. Referral & Onboarding KPIs

Key KPIs

• Total patient referrals tracks how many new patients enter the access workflow, helping teams understand overall demand and program growth.
• Referral source mix highlights where referrals originate such as HCPs, EHR systems, field teams, or PSPs allowing teams to compare channels and optimize outreach strategies.
• Missing info rate measures the percentage of referrals that require clarification. By reducing missing information, teams speed up onboarding and improve case accuracy.
• Time to case initiation (TAT) tells you how quickly a case gets initiated after a referral. Faster initiation leads to quicker benefits checks and a shorter path to therapy.
• Enrolment form completion rate shows the percentage of patients who complete HUB or PSP enrolment. Higher completion rates indicate stronger engagement and smoother program workflows.

Why it matters

Delays at this stage slow down the entire journey. Fast, complete referrals reduce onboarding friction and boost speed to therapy.

2. Prior Authorization (PA) KPIs

PA is often the biggest bottleneck. Tracking the right KPIs helps teams whittle down avoidable delays.

Key KPIs

• Submission Rate: This metric tracks how many patients receive a submitted PA request, and therefore highlights stronger case handling and fewer dropped referrals overall.
• Denial Reasons: It identifies why PAs face rejection, and therefore helps teams uncover recurring documentation issues and quickly improve future prior authorization submissions.
• Turnaround Time: This KPI measures decision time after PA submission, and consequently enables faster therapy access, reduced delays, and lower patient abandonment risk.
• Reversal / Appeal Success Rate: It shows how many denied PAs get overturned after appeal, and therefore reflects strong follow up, payer coordination, and improved documentation quality.
• Approval Rate: This metric tracks how many PA requests receive approval, and thus signals strong payer alignment, accurate documentation, and consistent case management performance.

Why it matters

High denial rates signal documentation issues, payer resistance, or unmet criteria guiding field and PSP interventions.

3. Fulfilment & Speed to Therapy KPIs

Once approved, patients must receive medication quickly and smoothly.

Key KPIs

• Time from Rx to First Fill: Measures the total time it takes for a patient to receive their first medication after the prescription is written. Shorter timelines mean faster access and lower risk of drop off.
• Specialty Pharmacy Dispense Time: Tracks how long the specialty pharmacy takes to process, prepare, and dispense the medication once all approvals are in place. It reflects operational efficiency and patient readiness.
• Abandonment Rate Before First Fill: Shows the percentage of patients who stop the process or never receive their first dose despite being prescribed the therapy. High abandonment usually indicates delays, cost barriers, or communication gaps.
• Shipment Delays / Failures: Measures how often medication shipments are delayed, rerouted, or fail to reach the patient. These issues directly affect treatment start dates and patient satisfaction.

Why it matters

Slow fulfilment is one of the most expensive leaks in specialty pharma. Every day lost may lead to abandonment.

Why These KPIs Matter More Today

Specialty therapies are becoming more complex, payer requirements tougher, and patient expectations higher. With data scattered across HUBs, SPs, EHR systems, and support partners, teams can’t rely on manual reporting anymore.

A strong KPI framework helps teams:

• Identify bottlenecks early
• Reduce approval and fulfilment delays
• Improve adherence and persistence
• Support payer strategy and field insights
• Deliver better patient experiences

Ultimately, these KPIs bring clarity to the patient journey helping more patients start and stay on therapy without unnecessary hurdles.

Challenges in Fulfilment & Speed to Therapy

• Complex insurance steps (PA, BV, and re verification) can slow down the path to dispensing, increasing patient frustration.
• High coordination demand between HCPs, HUBs, and specialty pharmacies often leads to communication gaps.
• Shipping dependencies weather, courier issues, or incorrect addresses can delay or fail medication delivery.
• Cost barriers or unclear out of pocket estimates can cause patients to pause or abandon therapy before the first fill.
• Operational bottlenecks at specialty pharmacies may extend processing times, especially for high volume or cold chain products.

Conclusion

A streamlined fulfilment and speed to therapy process is essential to ensure patients start treatment quickly and without unnecessary friction. By tracking Patient Access KPIs such as time to first fill, dispense efficiency, abandonment rates, and shipment reliability, pharma teams can pinpoint delays and take targeted action. Ultimately, improving these metrics leads to faster access, higher patient satisfaction, and better overall therapy outcomes.